Conduent Launches GenAI Solution for FDA Compliance
Conduent Incorporated (Nasdaq: CNDT), a global business solutions and services company, has introduced a new GenAI-powered tool designed to transform the detection of reportable events.
Revolutionizing Pharma and Life Sciences Compliance
The solution, built on Microsoft Azure OpenAI, automates the identification of reportable events for pharmaceutical and life sciences companies, covering every customer communication channel.
Key Features
- Advanced GenAI technology for enhanced event detection
- Comprehensive monitoring across all customer interactions
- Ensures adherence to FDA compliance standards
Powered by Microsoft Azure OpenAI, the new solution automates reportable event detection for Pharma & Life Sciences companies across every customer channel.
Media and Investor Contacts
- Media: Sean Collins, Conduent, +1-310-497-9205, [email protected]
- Investor Relations: Joshua Overholt, Conduent, [email protected]
Summary: Conduent’s new GenAI-driven tool sets a fresh benchmark in FDA compliance by automating reportable event detection across all Pharma and Life Sciences channels, enhancing accuracy and efficiency.